Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review.

Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, Young G, Bidlingmaier C, Brandao LR, Ettingshausen CE, Gringeri A, Kenet G, Knöfler R, Kreuz W, Kurnik K, Manner D, Santagostino E, Mannucci PM, Nowak-Göttl U (2010)

In: Journal of Thrombosis and Haemostasis, 8(6).

Research article (journal)

Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review

Iorio A, Halimeh S, Bidlingmaier C, Ettingshausen CE, Gringeri A, Holzhauer S, Knofler R, Kreuz W, Kurnik K, Manner D, Santagostino E, Mannucci PM, Nowak-Gottl U (2010)

In: Haemophilia, 16(2).

Research article (journal)

TNM STAGING IN EWING SARCOMAS

Juergens H, Manner D, Gerss J, Ranft A, Paulussen M, Dirksen U (2009)

In: Pediatric Blood and Cancer, 53(5).

Research article (journal)

Impact of Treatment Intensity and Factor VIII Products On the Development On High Titre Inhibitors in Children with Severe Hemophilia A: Results of a Non-Concurrent Cohort Study.

Kurnik K, Halimeh S, Manner D, Holzhauer S, Ettingshausen CE, Schobess R, Nowak-Gottl U (2009)

In: Blood, 114(22).

Research article (journal)

Publications

Contact

Top-Links

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, Young G, Bidlingmaier C, Brandao LR, Ettingshausen CE, Gringeri A, Kenet G, Knöfler R, Kreuz W, Kurnik K, Manner D, Santagostino E, Mannucci PM, Nowak-Göttl U (2010) In: Journal of Thrombosis and Haemostasis, 8(6). Research article (journal)
Long-term prophylactic treatment of juvenile von Willebrand type 2 and 3 patients with two different von Willebrand factor concentrates a two-center cohort study Halimeh S, Krumpel A, Rott H, Manner D, Mesters R, Nowak-Gottl U (2010) In: Haemophilia, 16 Suppl.. Research article (journal)
Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review Iorio A, Halimeh S, Bidlingmaier C, Ettingshausen CE, Gringeri A, Holzhauer S, Knofler R, Kreuz W, Kurnik K, Manner D, Santagostino E, Mannucci PM, Nowak-Gottl U (2010) In: Haemophilia, 16(2). Research article (journal)
Inhibitors in children with severe haemophilia A treated with recombinant and plasmatic FVIII products A hypothesis-based cumulative metaanalysis Halimeh S, Bidlingmaier C, Brandao LR, Ettingshausen CE, Holzhauer S, Kenet G, Knofler R, Kreuz W, Kurnik K, Manner D, Nowak-Gottl U (2010) In: Hämostaseologie, 30 Suppl.(4A). Research article (journal)
TNM STAGING IN EWING SARCOMAS Juergens H, Manner D, Gerss J, Ranft A, Paulussen M, Dirksen U (2009) In: Pediatric Blood and Cancer, 53(5). Research article (journal)
Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature Iorio A, Halimeh S, Bidlingmaier C, Brandao LR, Escuriola-Ettingshausen C, Goldenberg NA, Gringeri A, Holzhauer S, Kenet G, Knoefler R, Kreuz W, Kurnik K, Manner D, Marchesini E, Marcucci M, Santagostino E, Young G, Mannucci PM, Nowak-Gottl U (2009) In: Blood, 114(22). Research article (journal)
Impact of Treatment Intensity and Factor VIII Products On the Development On High Titre Inhibitors in Children with Severe Hemophilia A: Results of a Non-Concurrent Cohort Study. Kurnik K, Halimeh S, Manner D, Holzhauer S, Ettingshausen CE, Schobess R, Nowak-Gottl U (2009) In: Blood, 114(22). Research article (journal)